Crinetics Pharmaceuticals Other Current Assets

Crinetics Pharmaceuticals (CRNX) currently reports a other current assets of $23M as of June 2026. That compares with $21M in the prior-year period — up 10.7% year over year. Use the charts on this page to explore Crinetics Pharmaceuticals's other current assets history and peer comparisons.

Crinetics Pharmaceuticals's other current assets increased from $21M to $23M — a 10.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Crinetics Pharmaceuticals reported $23M in other current assets as of June 2026. That compares with $21M in the prior-year period — up 10.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Crinetics Pharmaceuticals, and consider following CRNX for alerts when major investors trade the stock.

Crinetics Pharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CRNX with unrelated industries.